HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
4
Cubic Digital Technology
300344
5
HNAC Technology
300490
US Stock MarketDetailed Quotes
TIL Instil Bio
- 23.3000
- +0.2900+1.26%
Trading Feb 18 14:14 ET
152.05MMarket Cap-2.02P/E (TTM)
24.8100High22.5388Low33.31KVolume23.0000Open23.0100Pre Close778.87KTurnover1.43%Turnover RatioLossP/E (Static)6.53MShares92.000052wk High0.86P/B54.19MFloat Cap9.620052wk Low--Dividend TTM2.33MShs Float589.8000Historical High--Div YieldTTM9.87%Amplitude6.0600Historical Low23.3820Avg Price1Lot Size
About Instil Bio Company
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
Company Profile
SymbolTIL
Company NameInstil Bio
Listing DateMar 19, 2021
Issue Price20.00
Founded2018
CEOMr. Bronson Crouch
MarketNASDAQ
Employees49
Fiscal Year Ends12-31
Address3963 Maple Avenue,Suite 350
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75225
Phone1-972-499-3350
Websitehttp://www.instilbio.com
Company Executives
- Name
- Position
- Salary
- Bronson Crouch
- Chief Executive Officer and Chairman of the Board
- 1.58M
- Dr. Sandeep Laumas, M.D.
- Principal Accounting Officer, Chief Financial Officer and Chief Business Officer
- 922.92K
- Dr. Neil Gibson,PhD
- Lead Independent Director
- 82.65K
- R. Kent McGaughy, Jr
- Independent Director
- 66.15K
- George Matcham, PhD
- Independent Director
- 57.15K
- Dr. Gwendolyn K. Binder-Scholl, M.D.,PhD
- Independent Director
- 57.15K
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025